- Home
- UHT vs LAB Comparison
UHT vs LAB Comparison
Compare UHT & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UHT
- LAB
- Stock Information
- Founded
- UHT 1986
- LAB 1999
- Country
- UHT United States
- LAB United States
- Employees
- UHT N/A
- LAB N/A
- Industry
- UHT Real Estate Investment Trusts
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- UHT Real Estate
- LAB Industrials
- Exchange
- UHT Nasdaq
- LAB Nasdaq
- Market Cap
- UHT 583.6M
- LAB 642.1M
- IPO Year
- UHT N/A
- LAB 2011
- Fundamental
- Price
- UHT $42.25
- LAB $2.18
- Analyst Decision
- UHT
- LAB Strong Buy
- Analyst Count
- UHT 0
- LAB 2
- Target Price
- UHT N/A
- LAB $2.88
- AVG Volume (30 Days)
- UHT 58.6K
- LAB 2.2M
- Earning Date
- UHT 10-24-2024
- LAB 10-30-2024
- Dividend Yield
- UHT 6.91%
- LAB N/A
- EPS Growth
- UHT 3.98
- LAB N/A
- EPS
- UHT 1.31
- LAB N/A
- Revenue
- UHT $99,899,000.00
- LAB $155,902,000.00
- Revenue This Year
- UHT N/A
- LAB $62.59
- Revenue Next Year
- UHT N/A
- LAB $13.23
- P/E Ratio
- UHT $32.07
- LAB N/A
- Revenue Growth
- UHT 3.43
- LAB 48.23
- 52 Week Low
- UHT $32.27
- LAB $1.21
- 52 Week High
- UHT $47.30
- LAB $3.04
- Technical
- Relative Strength Index (RSI)
- UHT 53.92
- LAB 65.04
- Support Level
- UHT $38.99
- LAB $1.66
- Resistance Level
- UHT $40.98
- LAB $2.26
- Average True Range (ATR)
- UHT 1.10
- LAB 0.14
- MACD
- UHT 0.27
- LAB 0.05
- Stochastic Oscillator
- UHT 92.47
- LAB 78.79
About UHT Universal Health Realty Income Trust
Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio which is located throughout the United States.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.